D A Westcott < D B Calne < D B Cook

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 67.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
003170 (2003)	J. Carr [Canada] ; R. De La Fuente-Fernández ; M. Schulzer ; E. Mak ; S M Calne ; D B Calne	Familial and sporadic Parkinson's disease usually display the same clinical features.
003278 (2003)	G V Mcdonnell [Canada] ; J. Cabrera-Gomez [Canada] ; D B Calne [Canada] ; D Kb Li [Canada] ; J. Oger [Canada]	Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions
003376 (2002)	S. Furtado [Canada] ; M. Farrer ; Y. Tsuboi ; M L Klimek ; R. De La Fuente-Fernández ; J. Hussey ; P. Lockhart ; D B Calne ; O. Suchowersky ; A J Stoessl ; Z K Wszolek	SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.
003585 (2001)	R. De La Fuente-Fernández [Canada] ; T J Ruth ; V. Sossi ; M. Schulzer ; D B Calne ; A J Stoessl	Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
003596 (2001)	R. De La Fuente-Fernández [Canada] ; J Q Lu ; V. Sossi ; S. Jivan ; M. Schulzer ; J E Holden ; C S Lee ; T J Ruth ; D B Calne ; A J Stoessl	Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
003597 (2001)	R. De La Fuente-Fernández [Canada] ; A S Lim ; V. Sossi ; J E Holden ; D B Calne ; T J Ruth ; A J Stoessl	Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.
003867 (2000)	R. De La Fuente-Fernández [Canada] ; A. Kishore ; D B Calne ; T J Ruth ; A J Stoessl	Nigrostriatal dopamine system and motor lateralization.
003882 (2000)	C S Lee [Canada] ; A. Samii ; V. Sossi ; T J Ruth ; M. Schulzer ; J E Holden ; J. Wudel ; P K Pal ; R. De La Fuente-Fernandez ; D B Calne ; A J Stoessl	In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
003890 (2000)	R. De La Fuente-Fernández [Canada] ; P K Pal ; F J Vingerhoets ; A. Kishore ; M. Schulzer ; E K Mak ; T J Ruth ; B J Snow ; D B Calne ; A J Stoessl	Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
003903 (2000)	P K Pal [Canada] ; D B Calne ; S. Calne ; J K Tsui	Botulinum toxin A as treatment for drooling saliva in PD.
003A04 (2000)	P K Pal [Canada] ; A. Samii [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; I M Turnbull [Canada] ; D B Calne [Canada]	Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years
003B51 (1999)	C R Honey [Canada] ; A J Stoessl ; J K Tsui ; M. Schulzer ; D B Calne	Unilateral pallidotomy for reduction of parkinsonian pain.
003B64 (1999)	A. Samii [Canada] ; I M Turnbull ; A. Kishore ; M. Schulzer ; E. Mak ; S. Yardley ; D B Calne	Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.
003B71 (1999)	A. Samii [Canada] ; K. Markopoulou ; Z K Wszolek ; V. Sossi ; T. Dobko ; E. Mak ; D B Calne ; A J Stoessl	PET studies of parkinsonism associated with mutation in the alpha-synuclein gene.
003B94 (1999)	D B Calne [Canada]	Differentiation of dopamine agonists and their role in the treatment of Parkinson's disease.
004108 (1997)	H. Shinotoh [Canada] ; F J Vingerhoets ; C S Lee ; R J Uitti ; M. Schulzer ; D B Calne ; J. Tsui	Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
004113 (1997)	H. Shinotoh [Canada] ; B. Thiessen ; B J Snow ; S. Hashimoto ; P. Macleod ; I. Silveira ; G A Rouleau ; M. Schulzer ; D B Calne	Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
004116 (1997)	A. Kishore [Canada] ; I M Turnbull ; B J Snow ; R. De La Fuente-Fernandez ; M. Schulzer ; E. Mak ; S. Yardley ; D B Calne	Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations.
004121 (1997)	D B Calne [Canada] ; R. De La Fuente-Fernández ; A. Kishore	Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.
004128 (1997)	R J Uitti ; H. Shinotoh ; M. Hayward ; M. Schulzer ; E. Mak ; D B Calne	"Familial Parkinson's disease"--a case-control study of families.
004353 (1996)	A. Kishore [Canada] ; Z K Wszolek ; B J Snow ; R. De La Fuente-Fernandez ; F. Arwert ; M. Wijker ; M. Schulzer ; D B Calne ; F J Vingerhoets	Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "D B Calne" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "D B Calne" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    D B Calne
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022